MedPath

Herbal treatment for premature greying of hair

Phase 2
Not yet recruiting
Conditions
Hair color and hair shaft abnormality, unspecified,
Registration Number
CTRI/2020/03/023897
Lead Sponsor
National Institute of Unani Medicine
Brief Summary

A clinical study on the topic efficacy of *Itrifal Sagheer* and Hair Oil formulation in premature hair greying (PHG) will be conducted in National Institute of Unani medicine, Bangalore. The formulation will be used in the form of *Itrifal*for oral use and Hair Oil for topical application. Total duration of the study is 60 days. The present test formulation has been extensively used by the eminent physicians in the treatment ofPremature Hair Greyingand is proverbially known for its efficacy and safety. Diagnosed patients of PHG fulfilling the inclusion criteria will be enrolled for the clinical trial. After obtaining their written informed consent they will be given test drug in the form of *Itrifal Sagheer*   orally and *hair oil* for topical application.Primary outcome measure is greying severity score (GSS) and the total score includes the scores of colour of the hair. while Secondary outcome measure includes photograph of the affected area of scalp.The efficacy of the treatment will be determined by decrease in grades from higher to lower i.e. from severe to moderate, moderate to mild and mild to healthy hair.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Clinically diagnosed patients of PHG.
  • Patients of either gender.
  • Patients in the age group of 15 to 35 years.
  • Patients who have agreed to sign the informed consent form and follow the protocol.
Exclusion Criteria
  • Patient suffering from any type of hair and scalp diseases like psoriasis, Eczema & Seborrhoic dermatitis.
  • Patient suffering from chronic systemic and metabolic diseases like DM, HIV, severe asthma, Cardiac diseases.
  • History of any treatment for hair loss and hair greying within the previous one month.
  • History of dyeing within the previous one month.
  • Premature aging disorder such as progeria.
  • Pregnant & Lactating Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Greying severity score (GSS)60 days
The total score includes the scores of colour of the hair.60 days
Secondary Outcome Measures
NameTimeMethod
Photograph of the affected area of scalp.60 days

Trial Locations

Locations (1)

National Institute of Unani Medicine

🇮🇳

Bangalore, KARNATAKA, India

National Institute of Unani Medicine
🇮🇳Bangalore, KARNATAKA, India
Mohammed Uwais Faisal
Principal investigator
8109223946
uwaisfaisal007@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.